Literature DB >> 31605814

Plutonium production and particles incorporation into the human body.

S A Romanov1, А V Efimov1, Е Е Aladova2, К G Suslova1, I S Kuznetsova1, А В Sokolova1, V V Khokhryakov1, S A Sypko1, M V Ishunina1, V F Khokhryakov1.   

Abstract

Plutonium is one of the most toxic radioactive substances known. The isotope 239Pu gained attention when it had become known as a potential explosive material for atomic bombs. This paper describes the main problems encountered during the early years of operation of the first plutonium production plant in the former Soviet Union, the Mayak Production Association (Mayak PA). Mayak PA caused severe radioactive contamination of the environment and exposure personnel and population living in the vicinity areas to high radiation doses. The authors focus on key findings of large-scale studies on the internal dosimetry of workers for use in assessment of radiological risks from exposure to plutonium. This work presents an overview of the important issues for inhalation dose assessments such as generation of plutonium particles, plutonium intake, dissolution of plutonium particles, distribution of plutonium in humans, related exposures and health effects. Understanding the relationship between health effects, radiation dose and route of exposure helps quantify the health risks associated with occupational exposure in the nuclear industry and validate the radiation protection standards used in the Russian Federation and worldwide.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Contamination; Environmental monitoring; Internal exposure; Nuclear weapon; Particle transport; Plutonium intake; Radiation protection; Radiation-related effects

Mesh:

Substances:

Year:  2019        PMID: 31605814     DOI: 10.1016/j.jenvrad.2019.106073

Source DB:  PubMed          Journal:  J Environ Radioact        ISSN: 0265-931X            Impact factor:   2.674


  1 in total

1.  Chelating Polymers for Targeted Decontamination of Actinides: Application of PEI-MP to Hydroxyapatite-Th(IV).

Authors:  Jeanne Fèvre; Elena Leveille; Aurélie Jeanson; Sabine Santucci-Darmanin; Valérie Pierrefite-Carle; Georges F Carle; Christophe Den Auwer; Christophe Di Giorgio
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.